Drugs Made In America Acquisition (DMII) Non-Current Assets (2024 - 2025)
Drugs Made In America Acquisition (DMII) posted quarterly Non-Current Assets of $504.9 million for Q4 2025, up 643545.94% year-over-year from N/an in Q4 2024, and up 0.96% quarter-over-quarter from $500.1 million in Q3 2025.
Drugs Made In America Acquisition (DMII) Non-Current Assets (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMII) has reported Non-Current Assets for 2 consecutive years, with $504.9 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Non-Current Assets rose 643545.94% year-over-year to $504.9 million; the TTM figure through Dec 2025 stood at $504.9 million (up 643545.94% YoY), while the FY2025 annual figure was $504.9 million, up 643545.94% from the prior year.
- Non-Current Assets improved to $504.9 million in Q4 2025 per DMII's latest filing, from $500.1 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $504.9 million in Q4 2025 and bottomed at $78449.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oxley Bridge Acquisition | 585.76 Mn | 585.76 Mn | - | 260.52 Mn |
| 2 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | 245.51 Mn |
| 3 | Drugs Made In America Acquisition | 506.00 Mn | 506.00 Mn | - | 513.88 Mn |
| 4 | Cantor Equity Partners IV | 468.00 Mn | 468.00 Mn | - | 464.79 Mn |
| 5 | New Providence Acquisition Corp. III | 401.18 Mn | 401.18 Mn | - | 315.49 Mn |
| 6 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | 98.24 Mn |
| 7 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 247.40 Mn |
| 8 | Pioneer Acquisition I | 390.89 Mn | 653.32 Mn | - | 262.91 Mn |
| 9 | Republic Digital Acquisition | 389.25 Mn | 388.51 Mn | - | 313.51 Mn |
| 10 | Gores Holdings X | 385.06 Mn | 384.87 Mn | - | 374.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 504.93 Mn |
| Sep 30, 2025 | 500.11 Mn |
| Dec 31, 2024 | 78,449.00 |